Editas Medicine, a transformative genome editing company, today announced it has secured a $43m Series A financing led by Flagship Ventures, Polaris Partners and Third Rock Ventures with participation from Partners Innovation Fund. ...
Tags: Editas Medicine, genome editing
Kala Pharmaceuticals, a developer of products that effectively penetrate the mucosal barrier to treat various debilitating diseases, has received $11.5m in Series A equity financing round, led by new and existing investors. Kala said ...
Chrysler Group will shift its Great Lakes Business Center and several corporate functions into downtown Detroit's Dime Building, which has been renamed to Chrysler House. The company will lease nearly 33,000sq ft of space in the ...